AFP and liver cancer: Alpha-fetoprotein a conventional predictive marker, suffers from inherent limitations in specificity, demonstrating significant elevations across a spectrum of pathological conditions, including active hepatitis, gonadal germ cell tumors, secondary liver cancer, and pregnancy—severely compromising diagnostic accuracy in HCC (Huang et al., 2024).